| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/04/1994 | US5352661 Bacillus thuringiensis isolate denoted B.t. PS81GG, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| 10/04/1994 | US5352660 Providing known concentrations of Src homology region and phosphorylated ligand which bind to form complex, incubating with test substance, assaying, comparing to control |
| 10/04/1994 | US5352659 Endothelin analogs and uses thereof |
| 10/04/1994 | US5352605 From cauliflower mosaic virus |
| 10/04/1994 | US5352604 Alkaline proteolytic enzyme and method of production |
| 10/04/1994 | US5352599 Co-enzyme-independent L-sorbosone dehydrogenase of gluconobacter oxydans: isolation, characterization, and cloning and autologus expression of the gene |
| 10/04/1994 | US5352596 Deletion and insertion is in an overlapping region of early protein O gene and the large latency transcript gene |
| 10/04/1994 | US5352595 Myod regulatory region |
| 10/04/1994 | US5352589 Deletion mutant of basic fibroblast growth factor and production thereof |
| 10/04/1994 | US5352588 Isolated DNA molecule |
| 10/04/1994 | US5352587 Genetic engineering |
| 10/04/1994 | US5352576 Method of determining the presence and titers of anti HIV-1 ag27bodies |
| 10/04/1994 | US5352575 Pseudorabies virus protein |
| 10/04/1994 | US5352476 Nutrient composition containing non-phosphorylated peptides from case in based material |
| 10/04/1994 | US5352451 Biological insect control agents and methods of use |
| 10/04/1994 | US5352450 Method for preparing vaccine for dental caries and vaccinal compositions for dental caries used as nasal drop |
| 10/04/1994 | US5352449 Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant |
| 10/04/1994 | US5352447 Coupling of an diphtheria with transferrin or monoclonal antibody |
| 10/04/1994 | CA1332223C Bone resorption |
| 10/02/1994 | CA2120302A1 Linear adhesion inhibitors |
| 10/01/1994 | CA2120065A1 Oilseed crops producing valuable seeds having altered amino acid composition and fatty acid composition |
| 09/30/1994 | WO1993019172A1 Methods for producing members of specific binding pairs |
| 09/30/1994 | CA2131151A1 Methods for producing members of specific binding pairs |
| 09/30/1994 | CA2119089A1 Tumor necrosis factor muteins |
| 09/29/1994 | WO1994022014A1 Parvovirus receptors and methods of use |
| 09/29/1994 | WO1994021814A1 Antibodies and assays for determining mutations in the apc gene |
| 09/29/1994 | WO1994021810A1 PRODUCTION OF POLY-β-HYDROXYBUTYRATE IN PROKARYOTIC HOST CELLS |
| 09/29/1994 | WO1994021809A1 Monocyte or macrophage migration factor |
| 09/29/1994 | WO1994021808A1 Process for preparing cancer vaccines |
| 09/29/1994 | WO1994021807A2 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 09/29/1994 | WO1994021806A1 Delivery system controlled through factors associated with hiv and cell |
| 09/29/1994 | WO1994021805A2 Method of controlling insects in plants |
| 09/29/1994 | WO1994021804A1 Methods and compositions for controlling plant development |
| 09/29/1994 | WO1994021803A2 Fruit ripening-related tomato dna, dna constructs, cells and plants derived therefrom |
| 09/29/1994 | WO1994021800A2 Protein tyrosine phosphatase ptp-s31 |
| 09/29/1994 | WO1994021798A1 Stimulation of immune response by viral protein |
| 09/29/1994 | WO1994021797A1 Nucleic acid pharmaceuticals |
| 09/29/1994 | WO1994021796A2 Maize chlorotic dwarf virus and resistance thereto |
| 09/29/1994 | WO1994021795A1 Novel pesticidal proteins and strains |
| 09/29/1994 | WO1994021794A1 Dna, dna constructs, cells and plants derived therefrom |
| 09/29/1994 | WO1994021793A1 Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter |
| 09/29/1994 | WO1994021792A2 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | WO1994021791A1 Agents for the prevention and treatment of breast cancer |
| 09/29/1994 | WO1994021790A1 Process for isolating genes and the gene causative of huntington's disease and differential 3' polyadenylation in the gene |
| 09/29/1994 | WO1994021789A1 Expression of heterologous polypeptides in halobacteria |
| 09/29/1994 | WO1994021788A2 Testing for infestation of rapeseed and other cruciferae by the fungus leptosphaeria maculans (blackleg infestation) |
| 09/29/1994 | WO1994021787A1 Method for defined deletions of dna |
| 09/29/1994 | WO1994021783A1 Transcription factor for regulation of the development of skin and hair |
| 09/29/1994 | WO1994021781A2 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 09/29/1994 | WO1994021688A1 Method of decoloring human serum albumin |
| 09/29/1994 | WO1994021687A1 A method of detecting rupture of the amniotic membranes in pregant mammals |
| 09/29/1994 | WO1994021686A1 Papp-a, its immunodetection and uses |
| 09/29/1994 | WO1994021685A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 09/29/1994 | WO1994021684A1 Botulinum toxin polypeptides and their use as vaccine enhancing agents |
| 09/29/1994 | WO1994021683A1 MUTATED FORM OF THE β-AMYLOID PRECURSOR PROTEIN GENE |
| 09/29/1994 | WO1994021682A1 Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides |
| 09/29/1994 | WO1994021681A1 Growth differentiation factor-8 |
| 09/29/1994 | WO1994021680A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 09/29/1994 | WO1994021679A1 Inhibitor of vascular endothelial cell growth factor |
| 09/29/1994 | WO1994021678A1 Hepatic parenchymal cell growth substance |
| 09/29/1994 | WO1994021675A2 T cell epitopes of ryegrass pollen allergen |
| 09/29/1994 | WO1994021673A1 Alpha-ketoamide derivatives as inhibitors of thrombosis |
| 09/29/1994 | WO1994021672A1 Novel antimicrobial peptides from bovine neutrophils |
| 09/29/1994 | WO1994021670A1 Human serotonin receptors, dna encoding the receptors, and uses thereof |
| 09/29/1994 | WO1994021669A1 Antigen related to inflammatory diseases |
| 09/29/1994 | WO1994021665A1 Cloned receptors and methods for screening |
| 09/29/1994 | WO1994021662A1 Diagnosis of human inflammatory bowel diseases and nucleic acid reagents therefor |
| 09/29/1994 | WO1994021661A1 Cellular regulation with riboregulators |
| 09/29/1994 | WO1994021660A1 Cloned human alpha1c adrenergic receptor |
| 09/29/1994 | WO1994021300A2 Novel agent for controlling cell activity |
| 09/29/1994 | WO1994021297A1 Recognin vaccines |
| 09/29/1994 | WO1994021291A1 Chlamydia vaccine and process |
| 09/29/1994 | WO1994021290A1 High molecular weight surface proteins of non-typeable haemophilus |
| 09/29/1994 | WO1994021287A1 Peptide coated dendritic cells as immunogens |
| 09/29/1994 | WO1994021282A1 Pharmaceutical compositions comprising a ligand complexed with a soluble receptor |
| 09/29/1994 | WO1994021278A1 Potassium channel blocking compounds and their use |
| 09/29/1994 | WO1994021277A1 Method of inhibiting pro-inflammatory mediator release from basophils and mast cells |
| 09/29/1994 | WO1994021273A2 USE OF ANGIOGENINE, AND/OR α1-MICROGLOBULINE AND/OR COMPLEMENTARY FACTOR D FOR LIMITING PROTEIN SECRETION |
| 09/29/1994 | WO1994021238A1 IgE-, IgE DEPENDENT HISTAMINE RELEASING FACTOR |
| 09/29/1994 | WO1994021126A1 Nucleic acid coding for a tumor rejection antigen precursor |
| 09/29/1994 | WO1994021115A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | WO1994021111A1 Transgenic mammalian as disease model |
| 09/29/1994 | WO1994018316A3 Apolipoprotein b mrna editing protein compositions and methods |
| 09/29/1994 | WO1994016094A3 Recombinant anti-vla4 antibody molecules |
| 09/29/1994 | WO1994015962A3 Derivatized calcitonins |
| 09/29/1994 | WO1994015958A3 Peptide inhibitors of cell adhesion |
| 09/29/1994 | WO1994014967A3 Cs31a protein capsule subunit modified by at least one heterologous peptide, cs31a protein capsule comprising said subunit, micro-organisms having such subunits on their outer membrane, and methods for preparing and using same |
| 09/29/1994 | WO1994013800A3 Mk protein preparation and use in cell culture |
| 09/29/1994 | WO1994012880A3 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 09/29/1994 | WO1994012220A3 Water soluble non-immunogenic polyamide cross-linking agents |
| 09/29/1994 | DE4309815A1 Method for isolating and using guanylate cyclase-activating peptide I (GAP-I) |
| 09/29/1994 | DE4309796A1 RIP, process for its preparation and pharmaceutical composition containing the RIP |
| 09/29/1994 | DE4309517A1 Process for the preparation of a stabilised streptokinase lyophilisate |
| 09/29/1994 | CA2159085A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | CA2158989A1 Alpha-ketoamide derivatives as inhibitors of thrombosis |
| 09/29/1994 | CA2158939A1 Protein tyrosine phosphatase ptp-s31 |
| 09/29/1994 | CA2158918A1 Process for isolating genes and the gene causative of huntington's disease and differential 3'polyadenylation in the gene |
| 09/29/1994 | CA2158748A1 Botulinum toxin polypeptides and their use as vaccine enhancing agents |
| 09/29/1994 | CA2158727A1 Parenchymal hepatocyte growth substances |
| 09/29/1994 | CA2158658A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |